Sahar Salehi

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Jag är kirurg och ansvarig för ovarialcancer vid patientflöde
gynekologisk cancer, medicinsk enhet bäckencancer, tema cancer, Karolinska
Universitetssjukhuset och Biträdande Lektor i Lehti gruppen,
MTC, Karolinska Institutet.
I kliniken ligger mitt fokus på avancerad ovarialcancer kirurgi och robot
assisterad kirurgi hos kvinnor med endometrie- och livmoderhalscancer.
Min forskning är både klinisk och translationell med fokus på effekten av
kirurgisk behandling på utfall vid ovarial-, cervix-, och
endometriecancer.
I *Falconer gruppen, KBH* undersöker vi onkologiskt utfall relaterat till
kirurgisk modalitet vid cervix- och endometricancer och omfattning av
kirurgiska ingreppet vid ovarialcancer.
I *Lehti gruppen MTC, * undersöker vi hur det kirurgiska
traumat, kirurgins omfattning och lokalbedövning påverkar bukhinnans
inflammatoriska svar samt cancercellens förmåga att proliferera,
invadera, metastasera och bli resistent mot cytostatika behandling.
1997-2003 Läkarlinjen, Karolinska Institutet
2003-2004 Allmäntjänstgöring Sundery Sjukhus, Luleå
2004-2009 Specialisttjänstgöring Södersjukhuset, Stockholm
2009 Specialist i Obstetrik och Gynekologi
2010-2014 Subspecialist utbildning gynekologisk cancer, Karolinska
Universitetssjukhuset, Stockholm
2015 Certifierad Gynekologisk cancerkirurg
2018 Doktorsavhandling “Robot-assisted laparoscopy and sentinel node biopsy
in high risk endometrial cancer”

Forskningsbeskrivning

Ansvarig huvudprövare (PI) the *IPLA-OVCA trial*
(https://clinicaltrials.gov/ct2/show/NCT04065009)
Ansvarig medprövare (Co-PI) the *RACC trial*
(https://clinicaltrials.gov/ct2/show/NCT03719547), (http://racctrial.org)
Ansvarig huvudprövare (PI) *STOOVCA *(Stockholm Ovarian Cancer Project)
study group
-------- *Fem utvalda publikationer* ---------------------------------------
Ultra-radical upfront surgery does not improve survival in women with
advanced epithelial ovarian cancer
a natural experiment in a complete
population. Gynecologic
oncology 2020
https://www.sciencedirect.com/science/article/pii/S0090825820323842
[1]
/Falconer H, Joneborg U, Krawiec K, Palsdottir K, Bottai M, *SALEHI S.*/
Intraperitoneal ropivacaine reduces time interval to initiation of
chemotherapy after surgery for advanced ovarian cancer: randomised controlled
double-blind pilot study. British journal of anaesthesia 2020 124
5
562-570 https://bjanaesthesia.org/article/S0007-0912(20)30095-7/fulltext
[2]
/Hayden JM, Oras J, Block L, Thörn SE, Palmqvist C, * SALEHI S, *Nordstrom
JL, Gupta A/
Surgery performed later in the week is associated with failure to achieve
complete radical surgical resection in advanced ovarian cancer. Acta
oncologica (Stockholm, Sweden) 2020 59
7
760-765 https://www.tandfonline.com/doi/full/10.1080/0284186X.2020.1726456
[3]
/Palsdottir K, Joneborg U, Hasselgren E, Johansson H, *SALEHI S*/
Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer
(SHREC-trial)-the final step towards a paradigm shift in surgical staging.
European journal of cancer 2019 116
77-85 https://www.ejcancer.com/article/S0959-8049(19)30279-5/abstract [4]
/Persson J, *SALEHI S, *Bollino M, Lonnerfors C, Falconer H, Geppert B./
Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic
lymphadenectomy in women with high-risk endometrial cancer: A randomised
controlled trial. European journal of cancer 2017 79
81-89 https://www.ejcancer.com/article/S0959-8049(17)30877-8/abstract [5]
/*SALEHI S, *Åvall-Lundqvist E, Legerstam B, Carlson JW, Falconer H/
[1] https://www.sciencedirect.com/science/article/pii/S0090825820323842
[2] https://bjanaesthesia.org/article/S0007-0912(20)30095-7/fulltext
[3] https://www.tandfonline.com/doi/full/10.1080/0284186X.2020.1726456
[4] https://www.ejcancer.com/article/S0959-8049(19)30279-5/abstract
[5] https://www.ejcancer.com/article/S0959-8049(17)30877-8/abstract

Artiklar

Article: BRITISH JOURNAL OF ANAESTHESIA. 2024;:S0007-0912(24)00619-6
Effect of the local anaesthetic ropivacaine intraperitoneally during and after cytoreductive surgery on time-interval to adjuvant chemotherapy in advanced ovarian cancer: a randomised, double-blind phase III trial.
Hasselgren E; Groes-Kofoed N; Falconer H; Björne H; Zach D; Hunde D; Johansson H; Asp M; Kannisto P; Gupta A; Salehi S
Article: EUROPEAN JOURNAL OF CANCER. 2024;211:114310
Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study
Bizzarri N; Querleu D; Ramirez PT; Dostalek L; van Lonkhuijzen LRCW; Giannarelli D; Lopez A; Salehi S; Ayhan A; Kim SH; Ortiz DI; Klat J; Landoni F; Pareja R; Manchanda R; Kostun J; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Dos Reis R; Anchora LP; Amaro K; Akilli H; Abu-Rustum NR; Salcedo-Hernandez RA; Javurkova V; Mom CH; Falconer H; Scambia G; Cibula D
Article: ECLINICALMEDICINE. 2024;73:102696
Oncologic outcomes after Total Mesometrial Resection (TMMR) or treatment according to current international guidelines in FIGO (2009) stages IB1-IIB cervical cancer: an observational cohort study
Falconer H; Norberg-Hardie A; Salehi S; Alfonzo E; Weydandt L; Dornhoefer N; Wolf B; Hoeckel M; Aktas B
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2023;102(12):1653-1660
Incidence of and survival after surgical intervention for bowel obstruction in women with advanced ovarian cancer
Palsdottir K; Salehi S; Johansson H; Groes-Kofoed N; Falconer H; Joneborg U
Article: MOLECULAR CANCER THERAPEUTICS. 2023;22(11):1319-1331
Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model
Monzo HJ; Kalander K; Hyytiainen MM; Elbasani E; Wall J; Moyano-Galceran L; Tanjore Ramanathan J; Jukonen J; Laakkonen P; Ristimaki A; Carlson JW; Lehti K; Salehi S; Puolakkainen P; Haglund C; Seppanen H; Leppa S; Ojala PM
Article: NPJ PRECISION ONCOLOGY. 2023;7(1):111
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients
Akerlund E; Gudoityte G; Moussaud-Lamodiere E; Lind O; Bwanika HC; Lehti K; Salehi S; Carlson J; Wallin E; Fernebro J; Ostling P; Kallioniemi O; Joneborg U; Seashore-Ludlow B
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2023;229(4):428.e1-428.e12
Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study
Bizzarri N; Querleu D; Dostalek L; van Lonkhuijzen LRCW; Giannarelli D; Lopez A; Salehi S; Ayhan A; Kim SH; Ortiz DI; Klat J; Landoni F; Pareja R; Manchanda R; Kostun J; Ramirez PT; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Dos Reis R; Anchora LP; Amaro K; Akilli H; Abu-Rustum NR; Salcedo-Hernandez RA; Javurkova V; Mom CH; Scambia G; Falconer H; Cibula D
Article: EUROPEAN JOURNAL OF CANCER. 2023;185:61-68
A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases
Wenzel HHB; Hardie AN; Moncada-Torres A; Hogdall CK; Bekkers RLM; Falconer H; Jensen PT; Nijman HW; van der Aa MA; Martin F; van Gestel AJ; Lemmens VEPP; Dahm-Kahler P; Alfonzo E; Persson J; Ekdahl L; Salehi S; Froding LP; Markauskas A; Fuglsang K; Schnack TH
Article: GYNECOLOGIC ONCOLOGY. 2023;170:259-265
Survival and chance of reversal after intestinal stoma formation during cytoreductive surgery for advanced ovarian cancer; a population-based cohort study
Kofoed NG; Falconer H; Vanky H; Johansson H; Abraham-Nordling M; Salehi S
Article: OBSTETRICS AND GYNECOLOGY. 2023;141(1):207-214
Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy
Bizzarri N; Dostalek L; van Lonkhuijzen LRCW; Giannarelli D; Lopez A; Falconer H; Querleu D; Ayhan A; Kim SH; Ortiz DI; Klat J; Landoni F; Rodriguez J; Manchanda R; Kostun J; Ramirez PT; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Dos Reis R; Pedone Anchora L; Amaro K; Salehi S; Akilli H; Abu-Rustum NR; Salcedo-Hernandez RA; Javurkova V; Mom CH; Scambia G; Cibula D
Article: GYNECOLOGIC ONCOLOGY. 2023;168:151-156
Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN project
Dostalek L; Benesova K; Klat J; Kim SH; Falconer H; Kostun J; dos Reis R; Zapardiel I; Landoni F; Ortizj DI; van Lonkhuijzen LRCW; Lopez A; Odetto D; Borcinova M; Jarkovsky J; Salehi S; Nemejcova K; Bajsova S; Park KJ; Javurkova V; Abu-Rustum NR; Dundr P; Cibula D
Article: ACTA ONCOLOGICA. 2021;60(11):1513-1519
Surgery performed later in the week is associated with inferior survival in advanced ovarian cancer
Groes-Kofoed N; Hasselgren E; Bjorne H; Johansson H; Falconer H; Salehi S
Article: EUROPEAN JOURNAL OF CANCER. 2021;158:111-122
The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer
Cibula D; Dostalek L; Jarkovsky J; Mom CH; Lopez A; Falconer H; Fagotti A; Ayhan A; Kim SH; Ortiz DI; Klat J; Obermair A; Landoni F; Rodriguez J; Manchanda R; Kostun J; dos Reis R; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Benesova K; Borcinova M; Pari D; Salehi S; Bizzarri N; Akilli H; Abu-Rustum NR; Salcedo-Hernandez RA; Javurkova V; Slama J; van Lonkhuijzen LRCW
Article: GYNECOLOGIC ONCOLOGY. 2021;161(2):402-407
Perioperative fluid balance and major postoperative complications in surgery for advanced epithelial ovarian cancer
Hasselgren E; Hertzberg D; Camderman T; Bjorne H; Salehi S
Article: EUROPEAN JOURNAL OF CANCER. 2021;145:38-43
Association between pelvic inflammatory disease and subsequent salpingectomy on the risk for ovarian cancer
Falconer H; Yin L; Salehi S; Altman D
Article: EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. 2021;47(2):353-359
Time-interval to adjuvant chemotherapy and postoperative management after upper abdominal surgical procedures in advanced ovarian cancer
Joneborg U; Palsdottir K; Farm E; Johansson H; Salehi S
Article: GYNECOLOGIC ONCOLOGY. 2020;159(1):58-65
Ultra-radical upfront surgery does not improve survival in women with advanced epithelial ovarian cancer; a natural experiment in a complete population
Falconer H; Joneborg U; Krawiec K; Palsdottir K; Bottai M; Salehi S
Article: ACTA ONCOLOGICA. 2020;59(7):760-765
Surgery performed later in the week is associated with failure to achieve complete radical surgical resection in advanced ovarian cancer
Palsdottir K; Joneborg U; Hasselgren E; Johansson H; Salehi S
Article: BRITISH JOURNAL OF ANAESTHESIA. 2020;124(5):562-570
Intraperitoneal ropivacaine reduces time interval to initiation of chemotherapy after surgery for advanced ovarian cancer: randomised controlled double-blind pilot study
Hayden JM; Oras J; Block L; Thorn S-E; Palmqvist C; Salehi S; Nordstrom JL; Gupta A
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2020;30(3):339-345
Pelvic sentinel lymph node biopsy in endometrial cancer-a simplified algorithm based on histology and lymphatic anatomy
Bollino M; Geppert B; Lonnerfors C; Falconer H; Salehi S; Persson J
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019;29(6):1072-1076
Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial
Falconer H; Palsdottir K; Stalberg K; Dahm-Kahler P; Ottander U; Lundin ES; Wijk L; Kimmig R; Jensen PT; Eriksson AGZ; Maenpaa J; Persson J; Salehi S
Article: EUROPEAN JOURNAL OF CANCER. 2019;116:77-85
Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging
Persson J; Salehi S; Bollino M; Lonnerfors C; Falconer H; Geppert B
Article: JOURNAL OF ROBOTIC SURGERY. 2019;13(2):351-353
Iliaco-enteric fistula after robot-assisted comprehensive surgical staging of endometrial cancer: a case report
Salehi S; Daryapeyma A; Suzuki C; Joneborg U; Falconer H
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019;29(1):86-93
Lymphedema, serious adverse events, and imaging 1 year after comprehensive staging for endometrial cancer: results from the RASHEC trial
Salehi S; Avall-Lundqvist E; Brandberg Y; Johansson H; Suzuki C; Falconer H
Article: ACTA ONCOLOGICA. 2018;57(12):1671-1676
Long-term quality of life after comprehensive surgical staging of high-risk endometrial cancer - results from the RASHEC trial
Salehi S; Brandberg Y; Avall-Lundqvist E; Suzuki C; Johansson H; Legerstam B; Falconer H
Article: ACTA ONCOLOGICA. 2018;57(6):820-824
Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre- and postoperative imaging
Salehi S; Mohammar R; Suzuki C; Joneborg U; Hjerpe E; Torbrand C; Falconer H
Article: EUROPEAN JOURNAL OF CANCER. 2017;79:81-89
Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial
Salehi S; Avall-Lundqvist E; Legerstam B; Carlson JW; Falconer H
Article: JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY. 2016;23(5):818-824
Improving Double Docking for Robot-assisted Para-aortic Lymphadenectomy in Endometrial Cancer Staging: Technique and Surgical Outcomes
Ekdahl L; Salehi S; Falconer H
Article: ACTA ONCOLOGICA. 2011;50(3):367-372
Reporting and incidence trends of hydatidiform mole in Sweden 1973-2004
Salehi S; Eloranta S; Johansson ALV; Bergstrom M; Lambe M
Visa fler

Alla övriga publikationer

Review: MATRIX BIOLOGY. 2023;121:217-228
The extracellular matrix-immune microenvironment crosstalk in cancer therapy: Challenges and opportunities
Closset L; Gultekin O; Salehi S; Sarhan D; Lehti K; Gonzalez-Molina J
Thesis / dissertation: 2018
Robot-assisted laparoscopy and sentinel node biopsy in high risk endometrial cancer
Salehi, Sahar
Letter: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2018;28(3):426-427
Letter to the Editor on the "European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery" by Querleu et al, Int J Gynecol Cancer 2016;26: 1354-1363
Salehi S; Hjerpe E; Falconer H
Review: LAKARTIDNINGEN. 2015;112:DLDT
[Increasingly better diagnosis and treatment of endometrial cancer].
Salehi S; Stålberg K; Marcickiewicz J; Rosenberg P; Falconer H

Anställningar

Anknuten till Forskning, Kvinnors och barns hälsa, Karolinska Institutet, 2024-2027
Biträdande Lektor, Kvinnors och barns hälsa, Karolinska Institutet, 2023-2024

Examina och utbildning

Docent, Gynekologisk cancerkirurgi, Karolinska Institutet, 2022
Medicine Doktorsexamen, Institutionen för kvinnors och barns hälsa, Karolinska Institutet, 2018
Läkarexamen, Karolinska Institutet, 2003

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI